NIH-funded research R01 grant

Connecting Sleep and Opioid Use Disorder through Brain Chemistry

Official title: Neurofunctional phenotyping to investigate the role of the orexin system at the intersection of opioid use disorder and insomnia

Funded at Virginia Commonwealth University · NIH-11195636 · Data updated 2026-11-12

This project looks at how a brain system called orexin connects sleep problems and opioid use disorder, hoping to find new ways to help people.

More Opioid Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVirginia Commonwealth University
NIH-funded
Lab location1 site (Richmond, United States)
Project startSeptember 30, 2024
Project endJuly 31, 2029
Funding year2025
Award (this year)$762,021
NIH project number5R01DA059483-02
Project IDNIH-11195636 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be adults aged 21 and older who are living with opioid use disorder and also experience insomnia.

Less likely to help

Patients not currently living with opioid use disorder or insomnia may not directly benefit from this specific research.

What this research studies

Many people with opioid use disorder (OUD) also experience insomnia, which can make OUD treatment less effective and increase the risk of overdose. This project explores how a specific brain system, called the orexin system, might link sleep issues with the brain's reward and stress responses in individuals with OUD. By using advanced brain imaging and other tools, we aim to identify the exact ways the orexin system influences these conditions. Our goal is to uncover new biological targets that could lead to more effective treatments for both OUD and related sleep problems.

Why it matters

Potential benefit: If successful, this work could lead to new medications or therapies that target the orexin system, helping individuals with opioid use disorder manage insomnia and reduce their risk of relapse.

How similar studies have gone: Preclinical studies in animal models have shown that targeting the orexin system can reduce opioid-seeking behaviors, suggesting a promising direction for this human-focused work.

Where this research is happening

  • Virginia Commonwealth University
    Richmond, United States
    Active

Researchers

  • Principal investigator: Martin, Caitlin Eileen — Virginia Commonwealth University
  • Study coordinator: Martin, Caitlin Eileen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.